$161.93
-3.05-1.85%
Last update: Nov 5, 5:59 PM

The average analyst price target for Novartis is $134.80, 16.5% below the current price. Of 10 analysts, 2 rate it Buy, 6 Hold and 2 Sell. Targets range from $118 to $170. The latest change came on Oct 30, 2026, when Deutsche Bank downgraded Novartis from Hold to Sell.
Price Target Range — 7 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months